BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26896649)

  • 1. Over-expression of survivin is a factor responsible for differential responses of ovarian cancer cells to S-allylmercaptocysteine (SAMC).
    Wu J; Zhao S; Zhang J; Qu X; Jiang S; Zhong Z; Zhang F; Wong Y; Chen H
    Exp Mol Pathol; 2016 Apr; 100(2):294-302. PubMed ID: 26896649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
    Howard EW; Lee DT; Chiu YT; Chua CW; Wang X; Wong YC
    Int J Cancer; 2008 May; 122(9):1941-8. PubMed ID: 18183597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions.
    Liang D; Qin Y; Zhao W; Zhai X; Guo Z; Wang R; Tong L; Lin L; Chen H; Wong YC; Zhong Z
    Cancer Lett; 2011 Nov; 310(1):69-76. PubMed ID: 21794975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel function of Id-1 in mediating the anticancer responses of SAMC, a water-soluble garlic derivative, in human bladder cancer cells.
    Hu H; Zhang XP; Wang YL; Chua CW; Luk SU; Wong YC; Ling MT; Wang XF; Xu KX
    Mol Med Rep; 2011; 4(1):9-16. PubMed ID: 21461556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of rapamycin and garlic-derived S-allylmercaptocysteine induces colon cancer cell apoptosis and suppresses tumor growth in xenograft nude mice through autophagy/p62/Nrf2 pathway.
    Li S; Yang G; Zhu X; Cheng L; Sun Y; Zhao Z
    Oncol Rep; 2017 Sep; 38(3):1637-1644. PubMed ID: 28737825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells.
    Xue H; Chen Y; Cai X; Zhao L; He A; Guo K; Zheng X
    Anticancer Drugs; 2013 Oct; 24(9):937-44. PubMed ID: 23921083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer.
    Sun P; Jiang Z; Chen X; Xue L; Mao X; Ruan G; Song Y; Mustea A
    Mol Med Rep; 2016 Aug; 14(2):1465-74. PubMed ID: 27356668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis of human gastric cancer cells line SGC 7901 induced by garlic-derived compound S-allylmercaptocysteine (SAMC).
    Yan JY; Tian FM; Hu WN; Zhang JH; Cai HF; Li N
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(6):745-51. PubMed ID: 23609357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation.
    Xiao D; Pinto JT; Soh JW; Deguchi A; Gundersen GG; Palazzo AF; Yoon JT; Shirin H; Weinstein IB
    Cancer Res; 2003 Oct; 63(20):6825-37. PubMed ID: 14583480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
    Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
    Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis by S-allylmercapto-L-cysteine, a biotransformed garlic derivative, on a human gastric cancer cell line.
    Lee Y
    Int J Mol Med; 2008 Jun; 21(6):765-70. PubMed ID: 18506370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-allylmercaptocysteine promotes MAPK inhibitor-induced apoptosis by activating the TGF-β signaling pathway in cancer cells.
    Tong D; Qu H; Meng X; Jiang Y; Liu D; Ye S; Chen H; Jin Y; Fu S; Geng J
    Oncol Rep; 2014 Sep; 32(3):1124-32. PubMed ID: 24970681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide.
    Shirin H; Pinto JT; Kawabata Y; Soh JW; Delohery T; Moss SF; Murty V; Rivlin RS; Holt PR; Weinstein IB
    Cancer Res; 2001 Jan; 61(2):725-31. PubMed ID: 11212275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel.
    Kar R; Palanichamy JK; Banerjee A; Chattopadhyay P; Jain SK; Singh N
    Clin Transl Oncol; 2015 Sep; 17(9):737-42. PubMed ID: 26033427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression.
    Chu Q; Ling MT; Feng H; Cheung HW; Tsao SW; Wang X; Wong YC
    Carcinogenesis; 2006 Nov; 27(11):2180-9. PubMed ID: 16675472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Garlic-derived compound S-allylmercaptocysteine (SAMC) is active against anaplastic thyroid cancer cell line 8305C (HPACC).
    Liu Y; Yan J; Han X; Hu W
    Technol Health Care; 2015; 23 Suppl 1():S89-93. PubMed ID: 26410334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-allylmercaptocysteine suppresses the growth of human gastric cancer xenografts through induction of apoptosis and regulation of MAPK and PI3K/Akt signaling pathways.
    Zhu X; Jiang X; Li A; Sun Y; Liu Y; Sun X; Feng X; Li S; Zhao Z
    Biochem Biophys Res Commun; 2017 Sep; 491(3):821-826. PubMed ID: 28642133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells.
    Jiang L; Luo RY; Yang J; Cheng YX
    Mol Med Rep; 2013 Feb; 7(2):425-30. PubMed ID: 23229441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer.
    Salzano G; Navarro G; Trivedi MS; De Rosa G; Torchilin VP
    Mol Cancer Ther; 2015 Apr; 14(4):1075-84. PubMed ID: 25657335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.